PTPN11-driven Erk1/2 activity is dominant in driving cellular proliferation and PTPN11-mediated antagonism of STAT3 phosphorylation prevails in the promotion of GBM cell death in response to EGFR and c-MET co-inhibition (100). This evidence concerns the gene PTPN11 and glioblastoma.